Six diseases reap benefits of biomarkers, genetic tests March 02, 2017 By Karen Appold Biomarker testing for harmful genetic mutations provides the opportunity to identify at-risk individuals who might benefit from risk modification strategies and/or enhanced disease screening. Genetic testing: Two downsides to consider February 25, 2017 By Karen Appold Genetic testing holds great promise, but there are some critical drawbacks to consider. New biomarker may predict treatment response in DME January 23, 2017 By Steve Lenier Researchers have identified a new biomarker they believe can be used as a predictor of vision change in patients with diabetic macular edema, either during the natural history of the disease or after undergoing anti-VEGF therapy. The biomarker is disorganization of the retinal inner layers, or DRIL. 4 biomarkers may improve Sjögren's syndrome treatment June 12, 2016 By Nancy Groves Research on the composition of tears and their secretory processes is generating insights that may lead to earlier detection and treatment of Sjögren’s syndrome. Glaucoma cure may be found in newly discovered biomarkers January 30, 2016 By Laird Harrison The study of biomarkers for glaucoma is pointing to promising avenues for new treatments, according to Vivek J. Srinivasan, PhD. AMCP: Include biomarker testing in coverage decisions April 05, 2014 More than 2,000 biomarker tests are available, and the NCCN Biomarkers Compendium contains information designed to support decision-making around the use of such testing in patients with cancer Biomarker signals deadly NEC in preemies January 29, 2014 By Lisa Hack Researchers have discovered a reliable biomarker for necrotizing enterocolitis (NEC), a potentially deadly bowel infection that affects primarily extremely low-birth-weight (LBW) infants. Pediatric nonalcoholic fatty liver disease Nonalcoholic fatty liver disease (NAFLD) in children is increasing, with studies showing it to be the most common liver abnormality in children aged 2 to 19 years. Genetic variants linked to lower urinary tract symptoms in African-Americans September 01, 2013 By Randy Dotinga In a study of African-American men, researchers say they’ve linked two genetic variants to severity of lower urinary tract symptoms related to BPH, giving scientists insight into the higher risk facing African-Americans.